Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

DTIL

Precision BioSciences (DTIL)

Precision BioSciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DTIL
DatumZeitQuelleÜberschriftSymbolFirma
20/09/202413h01Business WirePrecision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DTILPrecision BioSciences Inc
12/09/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
12/09/202413h15Business WirePrecision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical ExecutionNASDAQ:DTILPrecision BioSciences Inc
04/09/202413h01Business WirePrecision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare ConferenceNASDAQ:DTILPrecision BioSciences Inc
03/09/202414h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
03/09/202413h01Business WirePrecision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel DealNASDAQ:DTILPrecision BioSciences Inc
23/08/202413h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
23/08/202413h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
23/08/202413h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
23/08/202413h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
09/08/202413h01Business WirePrecision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple SclerosisNASDAQ:DTILPrecision BioSciences Inc
01/08/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DTILPrecision BioSciences Inc
01/08/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
01/08/202413h15Business WirePrecision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:DTILPrecision BioSciences Inc
31/07/202413h01Business WirePrecision BioSciences to Participate in Upcoming August Investor ConferencesNASDAQ:DTILPrecision BioSciences Inc
29/07/202422h15Business WirePrecision BioSciences to Report Second Quarter Results on August 1, 2024NASDAQ:DTILPrecision BioSciences Inc
08/07/202413h01Business WirePrecision BioSciences to Present at the Upcoming JonesTrading Healthcare Seaside SummitNASDAQ:DTILPrecision BioSciences Inc
01/07/202413h01Business WirePrecision BioSciences Announces its Addition to the Russell Microcap® IndexNASDAQ:DTILPrecision BioSciences Inc
27/06/202413h01Business WirePrecision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025NASDAQ:DTILPrecision BioSciences Inc
20/06/202413h00Business WirePrecision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical ReadinessNASDAQ:DTILPrecision BioSciences Inc
11/06/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
11/06/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
11/06/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
10/06/202421h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
10/06/202421h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
10/06/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
06/06/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/06/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/06/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/06/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:DTIL

Kürzlich von Ihnen besucht

Delayed Upgrade Clock